Marked increase in CD44-highly positive cells in hyperplastic thymuses from patients with myasthenia gravis

Muscle and Nerve

Volumn 23, Issue 4, 2000, Pages 507-513

  Utsugisawa, Kimiaki ^a   Nagane, Yuriko ^a   Tohgi, Hideo ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

B7 1; CD44; IL 2; Myasthenia gravis; Thymus

Indexed keywords

B7 ANTIGEN; CD45 ANTIGEN; HERMES ANTIGEN; INTERLEUKIN 2;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL MATURATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; THYMECTOMY; THYMUS HYPERPLASIA;

EID: 0034028547     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-4598(200004)23:4<507::aid-mus8>3.0.co;2-%23     Document Type: Article

References (25)

1. Bofill M, Janossy G, Willcox N, Chilosi M, Trejdosiewicz LK, Newsom-Davis J. Microenvironments in the normal thymus and the thymus in myasthenia gravis. Am J Pathol 1985;119: 462-473.
2. Cosi V, Romani A, Lombardi M, Raiola E, Bergamaschi R, Piccolo G, Citterio A, Berzuini C. Prognosis of myasthenia gravis: a retrospective study of 380 patients. J Neurol 1997; 244:548-555.
3. DeGrendele HC, Kosfiszer M, Estess P, Siegelman MH. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J Immunol 1997;159:2549-2553.
4. Essery G, Feldmann M, Lamb JR. Interleukin-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes. Immunology 1988;64:413-417.
5. Estess P, DeGrendele HC, Pascual V, Siegelman MH. Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity. J Clin Invest 1998;102: 1173-1182.
6. Freeman GJ, Gray GS, Gimmi CD, Lombard DB, Zhou LJ, White M, Fingeroth JD, Gribben JG, Nadler LM. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J Exp Med 1991;174:625-631.
7. Fujii Y, Hayakawa M, Nakahara K. Thymus cells in myasthenia gravis: a two-colour flow cytometric analysis of lymphocytes in the thymus and thymoma. J Neurol 1992;239:82-88.
8. Fujii Y, Lindstrom J. Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis. J Immunol 1988;141:3361-3369.
9. Goldstein IA, Zhou DFH, Picker LJ, Minty CN, Bargatze RF, Ding JF, Butcher EC. A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 1989;56:1063-1072.
10. Guerder S, Meyerhoff J, Flavell R. The role of the T cell costimulalor B7-1 in autoimmunity and the induction and maintenance of tolerance to peripherral antigen. Immunity 1994;1:155-166.
11. Huet S, Groux H, Caillou B, Valentin H, Prieur A, Bernard A, CD44 contributes to T cell activation. J Immunol 1989;143: 798-801.
12. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA. Binding of the B cell activation antigen B7 to CD28 costimutates T cell proliferation and interluekin 2 mRNA accumulation. J Exp Med 1991;173:721-730.
13. Lisak RP, Levinson AI, Zweiman B, Kornstein MJ. Antibodies to acetylcholine receptor and tetanus toxoid: in vitro synthesis by thymic lymphocytes. J Immunol 1986;137;1221-1225.
14. Mackay CR, Marston WL, Dudler L. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J Exp Med 1990;171:801-817.
15. Marx A, Schömig D, Schultz A, Gattenlöhner A, Jung A, Kirchner T, Melms A, Müller-Hermelink HK. Distribution of molecules mediating thymocyte-stroma interaction in human thymus, thymitis and thymic epithelial tumors. Thymus 1994; 23:83-93.
16. McIntosh KR, Linsley PS, Bacha PA, Drachman DB. Immunotherapy of experimental autoimmune myasthenia gravis: selective effects of CTLA4Ig and synergistic combination with an IL2-diphtheria toxin fusion protein. J Neuroimmunol 1998;87:136-146.
17. Melms A, Schalke BCG, Kirchner T, Müller-Hermelink HK, Albert E, Wekerle H. Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J Clin Invest 1988;81:902-908.
18. Naparstek Y, Holoshitz J, Eisenstein S, Reshef T, Rappaport S, Chemke J, Ben-Nun A, Cohen IR. Effector T lymphocyte line cells migrate to the thymus and persist there. Nature 1982; 300:262-264.
19. Newsom-Davis J, Willcox N, Calder L. Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes. N Engl J Med 1981;305:1313-1318.
20. high T cell population. Eur J Immunol 1993;23: 1057-1063.
21. Patrick J, Lindstrom J. Autoimmune response to acetylcholine receptor. Science 1973;180:871-872.
22. Rachmilewitz J, Tykocinski ML. Differential effects of chondroitin sulfates A and B on monocyte and B-cell activation: evidence for B-cell activation via a CD44-dependent pathway. Blood 1998;92:223-229.
23. Sommer N, Harcourt GC, Wilcox N, Beeson D, Newsom-Davis J. Acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients. Neurology 1991;41:1270-1276.
24. Stamenkovic I, Amiot M, Pesando JM, Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989;56:1057-1062.
25. Zhou T, Edwards CK, Mountz JD. Prevention of age-related T cell apoptosis defect in CD2-fas-transgenic mice. J Exp Med 1995;182:129-137.